Skip to main content
. 2017 Oct 31;44(6):617–630. doi: 10.1007/s10928-017-9553-x

Fig. 4.

Fig. 4

VPC with resistance model (upper panel) and with TGI base model (lower panel) after treatment with gefitinib at different dose levels